Month: October 2023
-
Keeping Conversations Positive with Precision Moderation
Sponsored content removed due to non-payment.
-
Taking a Break
We will resume our editorial posts on Monday 6 Nov. 2023.
-
Infographic – Little Trust in Companies’ A.I. Use
A poll in the U.S. shows a large majority of Americans who heard of artificial intelligence have very little or no trust that companies will use the technology responsibly.
-
Merger to Form Programmable Nano-Medicines Company
A life science venture investor is merging two of its biotechnology portfolio companies to form a single developer of nanoscale medications with programmable properties.
-
Coalition to Boost African Ancestry Genomic Data
An historically Black medical college and pharmaceutical industry group began a program to increase the numbers of people of African descent in genomic databases.
-
Organ Chip Devices to Model for Radiation Sickness
The U.S. government’s health preparedness agency awarded a contract with a university lab to explore organ models on chips to document effects of radiation sickness.
-
Start-Up Adapts Crispr for Molecular Detection, Raises $40M
A new company is underway that says it adapts the gene editing technique Crispr to make detecting nucleic acid targets like DNA or RNA faster and simpler.
-
High-Speed Biologic Injection Device Shown Feasible
A developer of an auto-injection technology says its device can deliver a biologic drug under the skin in a fraction of the time of conventional syringes.
-
Infographic – Q3 Life Science Venture Funds Tick Up
Venture investments in U.S. life science and biotechnology start-ups in the third quarter of 2023 rose from the previous two quarters to reach pre-pandemic levels.
-
Botox Vs Dysport: Similarities And Difference
It is essential for aesthetic practitioners to remain aware of the non-bioequivalency of these formulations and to exercise caution against direct dose conversions.